An advanced, intuitive platform for patients to enable flexible participation in clinical trials for new medicines and vaccines.
myMedidata provides a unified experience for patients, encompassing all of the capabilities of Medidata’s industry-leading, regulatory-compliant Rave platform and Patient Cloud tools.
Acorn AI is designed to make data liquid across the lifecycle and answer the most important questions.
The Impact of COVID-19 on Clinical Trial Sites
Medidata surveyed over 1,000 sites to see how the COVID-19 pandemic is affecting their ability to start, conduct and complete clinical studies.
COVID:19 and Clinical Trials: The Medidata Perspective
As the global impact of COVID-19 increases, Medidata is continuously analyzing its effect on patient study enrollment, the response by world regulatory bodies and which Medidata’s solutions can help address your COVID 19-related challenges.